281 related articles for article (PubMed ID: 16769036)
1. Dipeptide proline diphenyl phosphonates are potent, irreversible inhibitors of seprase (FAPalpha).
Gilmore BF; Lynas JF; Scott CJ; McGoohan C; Martin L; Walker B
Biochem Biophys Res Commun; 2006 Jul; 346(2):436-46. PubMed ID: 16769036
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, kinetic evaluation, and utilization of a biotinylated dipeptide proline diphenyl phosphonate for the disclosure of dipeptidyl peptidase IV-like serine proteases.
Gilmore BF; Carson L; McShane LL; Quinn D; Coulter WA; Walker B
Biochem Biophys Res Commun; 2006 Aug; 347(1):373-9. PubMed ID: 16824486
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel potent dipeptidyl peptidase IV inhibitors with enhanced chemical stability: interplay between the N-terminal amino acid alkyl side chain and the cyclopropyl group of alpha-aminoacyl-l-cis-4,5-methanoprolinenitrile-based inhibitors.
Magnin DR; Robl JA; Sulsky RB; Augeri DJ; Huang Y; Simpkins LM; Taunk PC; Betebenner DA; Robertson JG; Abboa-Offei BE; Wang A; Cap M; Xin L; Tao L; Sitkoff DF; Malley MF; Gougoutas JZ; Khanna A; Huang Q; Han SP; Parker RA; Hamann LG
J Med Chem; 2004 May; 47(10):2587-98. PubMed ID: 15115400
[TBL] [Abstract][Full Text] [Related]
4. Dipeptide boronic acid inhibitors of dipeptidyl peptidase IV: determinants of potency and in vivo efficacy and safety.
Connolly BA; Sanford DG; Chiluwal AK; Healey SE; Peters DE; Dimare MT; Wu W; Liu Y; Maw H; Zhou Y; Li Y; Jin Z; Sudmeier JL; Lai JH; Bachovchin WW
J Med Chem; 2008 Oct; 51(19):6005-13. PubMed ID: 18783201
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship of diaryl phosphonate esters as potent irreversible dipeptidyl peptidase IV inhibitors.
Belyaev A; Zhang X; Augustyns K; Lambeir AM; De Meester I; Vedernikova I; Scharpé S; Haemers A
J Med Chem; 1999 Mar; 42(6):1041-52. PubMed ID: 10090787
[TBL] [Abstract][Full Text] [Related]
6. Potent and selective proline derived dipeptidyl peptidase IV inhibitors.
Edmondson SD; Mastracchio A; Beconi M; Colwell LF; Habulihaz B; He H; Kumar S; Leiting B; Lyons KA; Mao A; Marsilio F; Patel RA; Wu JK; Zhu L; Thornberry NA; Weber AE; Parmee ER
Bioorg Med Chem Lett; 2004 Oct; 14(20):5151-5. PubMed ID: 15380217
[TBL] [Abstract][Full Text] [Related]
7. Rapid parallel synthesis of dipeptide diphenyl phosphonate esters as inhibitors of dipeptidyl peptidases.
Senten K; Daniëls L; Van der Veken P; De Meester I; Lambeir AM; Scharpé S; Haemers A; Augustyns K
J Comb Chem; 2003; 5(3):336-44. PubMed ID: 12739951
[TBL] [Abstract][Full Text] [Related]
8. Expression and enzymatic activity of dipeptidyl peptidase-IV in human astrocytic tumours are associated with tumour grade.
Stremenova J; Krepela E; Mares V; Trim J; Dbaly V; Marek J; Vanickova Z; Lisa V; Yea C; Sedo A
Int J Oncol; 2007 Oct; 31(4):785-92. PubMed ID: 17786309
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and SAR of potent and selective dipeptide-derived inhibitors for dipeptidyl peptidases.
Senten K; Van der Veken P; De Meester I; Lambeir AM; Scharpé S; Haemers A; Augustyns K
J Med Chem; 2003 Nov; 46(23):5005-14. PubMed ID: 14584950
[TBL] [Abstract][Full Text] [Related]
10. Dipeptidyl peptidase-IV in synovial fluid and in synovial fluid mononuclear cells of patients with rheumatoid arthritis.
Sromova L; Mareckova H; Sedova L; Balaziova E; Sedo A
Clin Chim Acta; 2010 Aug; 411(15-16):1046-50. PubMed ID: 20361950
[TBL] [Abstract][Full Text] [Related]
11. Irreversible inhibition of dipeptidyl peptidase 8 by dipeptide-derived diaryl phosphonates.
Van der Veken P; Soroka A; Brandt I; Chen YS; Maes MB; Lambeir AM; Chen X; Haemers A; Scharpé S; Augustyns K; De Meester I
J Med Chem; 2007 Nov; 50(23):5568-70. PubMed ID: 17958345
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl peptidase IV: development, design, synthesis and biological evaluation of inhibitors.
Borloo M; De Meester I
Verh K Acad Geneeskd Belg; 1994; 56(1):57-88. PubMed ID: 7911611
[TBL] [Abstract][Full Text] [Related]
13. Identification of the 170-kDa melanoma membrane-bound gelatinase (seprase) as a serine integral membrane protease.
Piñeiro-Sánchez ML; Goldstein LA; Dodt J; Howard L; Yeh Y; Tran H; Argraves WS; Chen WT
J Biol Chem; 1997 Mar; 272(12):7595-601. PubMed ID: 9065413
[TBL] [Abstract][Full Text] [Related]
14. Catalytic properties and inhibition of proline-specific dipeptidyl peptidases II, IV and VII.
Leiting B; Pryor KD; Wu JK; Marsilio F; Patel RA; Craik CS; Ellman JA; Cummings RT; Thornberry NA
Biochem J; 2003 Apr; 371(Pt 2):525-32. PubMed ID: 12529175
[TBL] [Abstract][Full Text] [Related]
15. Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
Augeri DJ; Robl JA; Betebenner DA; Magnin DR; Khanna A; Robertson JG; Wang A; Simpkins LM; Taunk P; Huang Q; Han SP; Abboa-Offei B; Cap M; Xin L; Tao L; Tozzo E; Welzel GE; Egan DM; Marcinkeviciene J; Chang SY; Biller SA; Kirby MS; Parker RA; Hamann LG
J Med Chem; 2005 Jul; 48(15):5025-37. PubMed ID: 16033281
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of prolyl oligopeptidase with a synthetic unnatural dipeptide.
Racys DT; Rea D; Fülöp V; Wills M
Bioorg Med Chem; 2010 Jul; 18(13):4775-82. PubMed ID: 20627594
[TBL] [Abstract][Full Text] [Related]
17. Specific and irreversible cyclopeptide inhibitors of dipeptidyl peptidase IV activity of the T-cell activation antigen CD26.
Nguyen C; Blanco J; Mazaleyrat JP; Krust B; Callebaut C; Jacotot E; Hovanessian AG; Wakselman M
J Med Chem; 1998 Jun; 41(12):2100-10. PubMed ID: 9622551
[TBL] [Abstract][Full Text] [Related]
18. Crystal structures of DPP-IV (CD26) from rat kidney exhibit flexible accommodation of peptidase-selective inhibitors.
Longenecker KL; Stewart KD; Madar DJ; Jakob CG; Fry EH; Wilk S; Lin CW; Ballaron SJ; Stashko MA; Lubben TH; Yong H; Pireh D; Pei Z; Basha F; Wiedeman PE; von Geldern TW; Trevillyan JM; Stoll VS
Biochemistry; 2006 Jun; 45(24):7474-82. PubMed ID: 16768443
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity relationship of N-acyl-Gly-, N-acyl-Sar- and N-blocked-boroPro inhibitors of FAP, DPP4, and POP.
Tran T; Quan C; Edosada CY; Mayeda M; Wiesmann C; Sutherlin D; Wolf BB
Bioorg Med Chem Lett; 2007 Mar; 17(5):1438-42. PubMed ID: 17174090
[TBL] [Abstract][Full Text] [Related]
20. Seprase, a membrane-bound protease, is overexpressed by invasive ductal carcinoma cells of human breast cancers.
Kelly T; Kechelava S; Rozypal TL; West KW; Korourian S
Mod Pathol; 1998 Sep; 11(9):855-63. PubMed ID: 9758365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
